查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573180

導管直接溶栓市場設備：按產品類型、材料類型、設備設計、應用、治療層級、患者年齡層和最終用戶 - 2025-2030 年全球預測

Catheter-Directed Thrombolysis Devices Market by Product Type, Material Type (Nylon, Polyurethane, Polyvinyl Chloride ), Device Design, Application, Therapeutic Class, Patient Age Group, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年導管直接溶栓器械市值為4.3258億美元，預計2024年將達到4.5745億美元，複合年成長率為5.31%，到2030年將達到6億美元，預計將達到2145萬美元。

用於血栓治療的導管直接溶栓（CDT）設備是溶栓治療和介入心血管設備市場中令人興奮的部分。其範圍圍繞著支持直接透過導管溶解血栓的微創手術，主要用於深層靜脈栓塞症、肺動脈栓塞和周邊血栓性栓塞症，門診護理和專業診所強調治療的必要性。心血管疾病盛行率的增加、久坐的生活方式和人口老化是推動市場規模擴大的主要成長要素。技術進步，例如改進的導管設計以及與成像技術的整合，凸顯了潛在的創新機會。公司應該專注於研究更有效的溶栓劑、更安全的程序，並可能使用人工智慧和機器學習來實現針對患者的治療策略。

主要市場統計
基準年[2023] 43258萬美元
預測年份 [2024] 45745萬美元
預測年份 [2030] 6.2145億美元
複合年成長率（%） 5.31%

主要成長領域包括擁有發達醫療基礎設施以及與數位醫療平台整合以提高手術效率和結果的新興市場。然而，高成本、嚴格的法規結構和潛在的程序併發症等挑戰可能會阻礙市場成長。此外，機械血栓切除術和非侵入性治療等替代方案的興起可能會限制採用率。智慧財產權障礙以及與現有製藥公司的競爭帶來了額外的挑戰。

為了利用這個機會，製造商應該投資研發，並專注於提高溶栓劑和生物相容性導管的安全性。為了解決這些限制，重點關注醫療保健專業人員的 CDT 技術教育和培訓有可能提高利用率。與臨床試驗機構的夥伴關係和策略聯盟可以提高已開發市場的可信度和接受度。因此，技術創新應優先考慮機器人技術和增強影像處理等跨領域技術的整合，以保持競爭優勢並解決發展中地區的進入壁壘，同時滿足監管要求。

市場動態：揭示快速發展的導管直接溶栓設備市場的關鍵市場洞察

供需的動態交互作用正在改變導管直接溶栓治療設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 微創手術的擴展推動了對導管直接溶栓治療設備的需求
    • 增加對研發活動的投資，以創新導管為基礎的血栓溶解治療方法
    • 增加醫療支出並專注於先進的患者照護解決方案
    • 醫療設備公司之間的聯盟和夥伴關係，以擴大產品範圍和效率
  • 市場限制因素
    • 導管溶栓設備核准的嚴格監管要求可能會延遲新產品的市場進入
    • 與直接導管溶栓相關的風險，例如出血和感染，可能會限制採用率
  • 市場機會
    • 先進影像技術的出現提高溶栓治療的準確性和有效性
    • 創新導致下一代導管直接溶栓系統的開發
    • 將人工智慧和機器學習整合到手術規劃和治療結果預測中
  • 市場挑戰
    • 導管直接溶栓治療裝置最佳操作所需的技術複雜性與專業知識
    • 溶栓治療市場中其他微創療法和藥物療法的競爭

波特五力：駕馭導管直接溶栓設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解導管直接溶栓設備市場的外部影響

外部宏觀環境因素在塑造導管直接溶栓設備市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解導管直接溶栓設備市場的競爭格局

對導管直接溶栓設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣導管直接溶栓設備市場供應商的績效評估

FPNV定位矩陣是評估導管直接溶栓設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了導管直接溶栓設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對導管直接溶栓設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 微創手術的擴展推動了對導管直接溶栓治療設備的需求
      • 增加對研發活動的投資，以創新導管為基礎的血栓溶解治療方法
      • 醫療保健成本上升並專注於先進的患者照護解決方案
      • 醫療設備公司之間的協作和夥伴關係，以提高產品採用率和效率
    • 抑制因素
      • 導管溶栓設備核准的嚴格監管要求可能會延遲新產品的市場進入
      • 與導管導引溶栓相關的風險，例如出血和感染，可能會限制實施率。
    • 機會
      • 引進先進影像技術，提升溶栓治療的準確性與有效性
      • 技術創新促進下一代導管引導溶栓系統的開發
      • 將人工智慧和機器學習整合到程式規劃和結果預測中
    • 任務
      • 最佳化操作基於導管的溶栓裝置所需的技術複雜性和專業知識。
      • 溶栓治療市場中替代微創療法和藥物療法的競爭
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章導管直接溶栓設備市場：依產品類型

  • 附屬裝置
    • 導管導引器
    • 導管導引線
    • 點滴幫浦
  • 溶栓輸液導管
    • 微注射導管
    • 標準溶栓輸注導管

第 7 章依材料類型分類的導管直接溶栓設備市場

  • 尼龍
  • 聚氨酯
  • 聚氯乙烯（PVC）
  • 矽膠

第8章導管直接溶栓裝置市場裝置設計

  • 雙腔
  • 多重腔
  • 單腔

第9章導管直接溶栓設備市場：依應用分類

  • 急性肢體缺血
  • 深層靜脈栓塞症
  • 肺動脈栓塞

第10章依治療層級分類的導管直接溶栓設備市場

  • 抗凝血物
  • 溶栓劑

第11章依病患年齡層別分類的導管直接溶栓裝置市場

  • 成人
  • 老年醫學
  • 小兒科

第12章導管直接溶栓設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第13章：美洲導管直接溶栓設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太導管直接溶栓器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章：歐洲、中東和非洲的導管直接溶栓裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C03AA

The Catheter-Directed Thrombolysis Devices Market was valued at USD 432.58 million in 2023, expected to reach USD 457.45 million in 2024, and is projected to grow at a CAGR of 5.31%, to USD 621.45 million by 2030.

Catheter-Directed Thrombolysis (CDT) devices, used in the medical treatment of blood clots, represent a focused segment within the larger thrombolytic therapy and interventional cardiovascular device markets. The scope revolves around aiding minimally invasive procedures to dissolve clots directly through a catheter, emphasizing their necessity in treating deep vein thrombosis, pulmonary embolism, and peripheral arterial thromboembolism, primarily in hospital settings, ambulatory care, and specialized clinics. The increasing prevalence of cardiovascular diseases, sedentary lifestyles, and aging populations are key growth drivers, promoting a larger market size. Technological advancements, such as improved catheter designs and integration with imaging technologies, highlight potential opportunities for innovation. Companies should focus on research into more efficient thrombolytic agents and safer procedure techniques, potentially using AI and machine learning for patient-specific treatment strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 432.58 million
Estimated Year [2024] USD 457.45 million
Forecast Year [2030] USD 621.45 million
CAGR (%) 5.31%

Key growth areas include emerging markets with healthcare infrastructure development, while collaboration with digital health platforms can improve procedural efficiency and outcomes. However, challenges such as high costs, stringent regulatory frameworks, and potential procedural complications could hinder market growth. Moreover, rising alternatives like mechanical thrombectomy and non-invasive treatments might limit the adoption rate. Intellectual property hurdles and competition from established pharmaceutical companies pose additional challenges.

To leverage opportunities, manufacturers should invest in R&D focused on enhancing safety profiles of thrombolytic agents and bio-compatible catheters. Addressing limitations, emphasis on education and training for healthcare professionals regarding CDT techniques can potentially boost usage rates. Partnerships and strategic alliances with institutions for clinical trials can foster credibility and acceptance in developed markets. Thus, innovation should prioritize integrating cross-disciplinary technologies such as robotics and enhanced imaging to maintain competitive advantage while meeting regulatory requirements and addressing the barriers to entry in developing regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
    • Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
    • Increasing healthcare expenditure and focus on advanced patient care solutions
    • Collaborations and partnerships among medical device companies to enhance product reach and efficiency
  • Market Restraints
    • Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
    • Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
  • Market Opportunities
    • Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
    • Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
    • Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
  • Market Challenges
    • Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
    • Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market

Porter's Five Forces: A Strategic Tool for Navigating the Catheter-Directed Thrombolysis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Catheter-Directed Thrombolysis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Catheter-Directed Thrombolysis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Catheter-Directed Thrombolysis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Catheter-Directed Thrombolysis Devices Market

A detailed market share analysis in the Catheter-Directed Thrombolysis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Catheter-Directed Thrombolysis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Catheter-Directed Thrombolysis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Catheter-Directed Thrombolysis Devices Market

A strategic analysis of the Catheter-Directed Thrombolysis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Catheter-Directed Thrombolysis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Asahi Intecc Co., Ltd., Bayer AG, Boston Scientific Corporation, BTG International Ltd., Cardinal Health, Inc., Cook Medical Inc., Cordis Corporation, Endocor GmbH, iVascular S.L.U., Koninklijke Philips N.V., Medline Industries, Inc., Medtronic plc, Merit Medical Systems, Inc., MicroVention, Inc., Penumbra Inc., Stryker Corporation, Teleflex Incorporated, and Terumo Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Catheter-Directed Thrombolysis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Accessory Devices and Thrombolytic Infusion Catheters. The Accessory Devices is further studied across Catheter Introducers, Guidewires, and Infusion Pumps. The Thrombolytic Infusion Catheters is further studied across Micro Infusion Catheters and Standard Thrombolytic Infusion Catheters.
  • Based on Material Type, market is studied across Nylon, Polyurethane, Polyvinyl Chloride (PVC), and Silicone.
  • Based on Device Design, market is studied across Dual Lumen, Multi-Lumen, and Single Lumen.
  • Based on Application, market is studied across Acute Limb Ischemia, Deep Vein Thrombosis, and Pulmonary Embolism.
  • Based on Therapeutic Class, market is studied across Anticoagulants and Thrombolytics.
  • Based on Patient Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
      • 5.1.1.2. Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
      • 5.1.1.3. Increasing healthcare expenditure and focus on advanced patient care solutions
      • 5.1.1.4. Collaborations and partnerships among medical device companies to enhance product reach and efficiency
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
      • 5.1.2.2. Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
      • 5.1.3.2. Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
      • 5.1.3.3. Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
      • 5.1.4.2. Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Catheter-Directed Thrombolysis Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessory Devices
    • 6.2.1. Catheter Introducers
    • 6.2.2. Guidewires
    • 6.2.3. Infusion Pumps
  • 6.3. Thrombolytic Infusion Catheters
    • 6.3.1. Micro Infusion Catheters
    • 6.3.2. Standard Thrombolytic Infusion Catheters

7. Catheter-Directed Thrombolysis Devices Market, by Material Type

  • 7.1. Introduction
  • 7.2. Nylon
  • 7.3. Polyurethane
  • 7.4. Polyvinyl Chloride (PVC)
  • 7.5. Silicone

8. Catheter-Directed Thrombolysis Devices Market, by Device Design

  • 8.1. Introduction
  • 8.2. Dual Lumen
  • 8.3. Multi-Lumen
  • 8.4. Single Lumen

9. Catheter-Directed Thrombolysis Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Acute Limb Ischemia
  • 9.3. Deep Vein Thrombosis
  • 9.4. Pulmonary Embolism

10. Catheter-Directed Thrombolysis Devices Market, by Therapeutic Class

  • 10.1. Introduction
  • 10.2. Anticoagulants
  • 10.3. Thrombolytics

11. Catheter-Directed Thrombolysis Devices Market, by Patient Age Group

  • 11.1. Introduction
  • 11.2. Adults
  • 11.3. Geriatrics
  • 11.4. Pediatrics

12. Catheter-Directed Thrombolysis Devices Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Americas Catheter-Directed Thrombolysis Devices Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Catheter-Directed Thrombolysis Devices Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Catheter-Directed Thrombolysis Devices Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. Asahi Intecc Co., Ltd.
  • 4. Bayer AG
  • 5. Boston Scientific Corporation
  • 6. BTG International Ltd.
  • 7. Cardinal Health, Inc.
  • 8. Cook Medical Inc.
  • 9. Cordis Corporation
  • 10. Endocor GmbH
  • 11. iVascular S.L.U.
  • 12. Koninklijke Philips N.V.
  • 13. Medline Industries, Inc.
  • 14. Medtronic plc
  • 15. Merit Medical Systems, Inc.
  • 16. MicroVention, Inc.
  • 17. Penumbra Inc.
  • 18. Stryker Corporation
  • 19. Teleflex Incorporated
  • 20. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY CATHETER INTRODUCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MICRO INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STANDARD THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DUAL LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACUTE LIMB ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY CATHET